Resilient Drug Supply Project

The Resilient Drug Supply Project focuses on the supply chains and global disruptions for the most critical drugs for life-saving and life-sustaining treatment (funded by a gift from the Walton Family Foundation). Outcomes of this research will improve the healthcare supply system’s ability to maintain a steady and adequate supply of critical medicines and supplies worldwide. 

About RDS Project

156 Critical Acute Drugs list. - Drugs "needed in acute care, whose absence—or the lack of availability of an effective substitute—will lead to serious health outcomes, including death or the inability to provide humane care."


Face mask sign on New York City subway train

East Coast sees drop in COVID-19 cases as other areas surge

New data show that 600 frontline US health workers have died from COVID-19.

Business video conference

What can firms do now in the midst of a pandemic?

Companies need to get study labor laws, take steps to ensure employee health, analyze supply chains, and more.

Assembly line pills

Experts say COVID-19 will likely lead to US drug shortages

The US depends heavily on drugs made in other countries, especially India and China.

Drug production line

FDA floats drug expiration changes, other steps to address shortages

Fully 56% of hospitals reported changing patient care or delaying therapy because of drug shortages.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»


Grant support for RDS provided by

Unrestricted financial support provided by

Bentson Foundation